Litcius/Paper detail

Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression

Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Cynthia Putri, Andree Kurniawan

2021Diabetes Research and Clinical Practice62 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMeta-analysisCoronavirus disease 2019 (COVID-19)CoronavirusAgonistMeta-regressionGlucagon-like peptide-1Diabetes mellitus2019-20 coronavirus outbreakGlucagon-like peptide 1 receptorDiseaseInternal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorVirologyEndocrinologyType 2 diabetesInfectious disease (medical specialty)OutbreakDiabetes Treatment and ManagementCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patients
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression | Litcius